Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
107,006,728
-
Share change
-
-53,738,608
-
Total reported value
-
$20,903,721,082
-
Put/Call ratio
-
61%
-
Price per share
-
$195.69
-
Number of holders
-
388
-
Value change
-
-$9,082,051,270
-
Number of buys
-
186
-
Number of sells
-
288
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q3 2020
As of 30 Sep 2020,
SEATTLE GENETICS INC - COM (SGEN) was held by
388 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,006,728 shares.
The largest 10 holders included
Capital International Investors, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, STATE STREET CORP, Nuveen Asset Management, LLC, and FMR LLC.
This page lists
388
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.